Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis

Genomics

Volumn 94, Issue 3, 2009, Pages 153-160

  Bettoni, Fabiana ^a   Filho, Fernando Camargo ^a   Grosso, Daniela M ^a   Galante, Pedro A F ^a   Parmigiani, Raphael B ^a   Geraldo, Murilo V ^a   Henrique Silva, Flávio ^b   Oba Shinjo, Sueli M ^c   Marie, Suely K N ^c   Soares, Fernando A ^d   Brentani, Helena P ^d   Simpson, Andrew J G ^e   de Souza, Sandro J ^a   Camargo, Anamaria A ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d A C CAMARGO CANCER CENTER   (Brazil)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

ESTs; FAM46D; Gene expression profiling; Immunotherapy; Tumor antigens

Indexed keywords

CANCER TESTIS ANTIGEN; FAMILY WITH SEQUENCE SIMILARITY 46 MEMBER D; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 10; MELANOMA ANTIGEN 3; NY ESO 1 ANTIGEN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; EXPRESSED SEQUENCE TAG; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN GENOME; IMMUNOGENICITY; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; UTERINE CERVIX CANCER;

ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; DATABASES, NUCLEIC ACID; EXPRESSED SEQUENCE TAGS; GENOME, HUMAN; HUMANS; MALE; NEOPLASM PROTEINS; NEOPLASMS; RECOMBINANT PROTEINS; TESTIS; TUMOR CELLS, CULTURED;

EID: 68549105875     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2009.06.001     Document Type: Article

References (49)

1. Simpson A.J., Caballero O.L., Jungbluth A., Chen Y.T., and Old L.J. Cancer/testis antigens, gametogenesis and cancer. Nat. Rev., Cancer 5 (2005) 615-625
2. Scanlan M.J., Gure A.O., Jungbluth A.A., Old L.J., and Chen Y.T. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol. Rev. 188 (2002) 22-32
3. Scanlan M.J., Simpson A.J., and Old L.J. The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4 (2004) 1
4. Zendman A.J., Ruiter D.J., and Van Muijen G.N. Cancer/testis-associated genes: identification, expression profile, and putative function. J. Cell. Physiol. 194 (2003) 272-288
5. Davis D., Chen W., Jackson H., Parente P., Shackleton M., Hopkins W., Chen Q., Dimopoulos N., Luke T., Murphy R., Scott A.M., Maraskovsky E., McArthur G., MacGregor D., Sturrock S., Tai T.Y., Green S., Cuthbertson A., Maher D., Miloradovic L., Mitchell S.V., Ritter G., Jungbluth A.A., Chen Y.T., Gnjatic S., Hoffman E.W., Old L.J., and Cebon J.S. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10697-10702
6. Marchand M., van Baren N., Weynants P., Brichard V., Dreno B., Tessier M.H., Rankin E., Parmiani G., Arienti F., Humblet Y., Bourlond A., Vanwijck R., Lienard D., Beauduin M., Dietrich P.Y., Russo V., Kerger J., Masucci G., Jager E., De Greve J., Atzpodien J., Brasseur F., Coulie P.G., van der Bruggen P., and Boon T. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 80 (1999) 219-230
7. Adams S., O'Neill D.W., Nonaka D., Hardin E., Chiriboga L., Siu K., Cruz C.M., Angiulli A., Angiulli F., Ritter E., Holman R.M., Shapiro R.L., Berman R.S., Berner N., Shao Y., Manches O., Pan L., Venhaus R.R., Hoffman E.W., Jungbluth A., Gnjatic S., Old L., Pavlick A.C., and Bhardwaj N. Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. J. Immunol. 181 (2008) 776-784
8. Romero P. Current state of vaccine therapies in non-small-cell lung cancer. Clin. Lung Cancer 9 Suppl. 1 (2008) S28-36
9. Traversari C., van der Bruggen P., Van den Eynde B., Hainaut P., Lemoine C., Ohta N., Old L., and Boon T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35 (1992) 145-152
10. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van den Eynde B., Knuth A., and Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254 (1991) 1643-1647
11. Boel P., Wildmann C., Sensi M.L., Brasseur R., Renauld J.C., Coulie P., Boon T., and van der Bruggen P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2 (1995) 167-175
12. Van den Eynde B., Peeters O., De Backer O., Gaugler B., Lucas S., and Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182 (1995) 689-698
13. Sahin U., Tureci O., and Pfreundschuh M. Serological identification of human tumor antigens. Curr. Opin. Immunol. 9 (1997) 709-716
14. Sahin U., Tureci O., Schmitt H., Cochlovius B., Johannes T., Schmits R., Stenner F., Luo G., Schobert I., and Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11810-11813
15. Lethe B., Lucas S., Michaux L., De Smet C., Godelaine D., Serrano A., De Plaen E., and Boon T. LAGE-1, a new gene with tumor specificity. Int. J. Cancer 76 (1998) 903-908
16. Gure A.O., Stockert E., Arden K.C., Boyer A.D., Viars C.S., Scanlan M.J., Old L.J., and Chen Y.T. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int. J. Cancer 85 (2000) 726-732
17. Westbrook A., Diekman A.B., Klotz K.L., Khole V., von Kap-Herr C., Golden W.L., Eddy R.L., Shows T.B., Stoler M.H., Lee C.Y., Flickinger C.J., and Herr J.C. Spermatid-specific expression of the novel X-linked gene product SPAN-X localized to the nucleus of human spermatozoa. Biol. Reprod. 63 (2000) 469-481
18. Zendman A.J., Cornelissen M., Weidle U.H., Ruiter D.J., and van Muijen G.N. CTp11, a novel member of the family of human cancer/testis antigens. Cancer Res. 59 (1999) 6223-6229
19. de Wit N.J., Weidle U.H., Ruiter D.J., and van Muijen G.N. Expression profiling of MMA-1a and splice variant MMA-1b: new cancer/testis antigens identified in human melanoma. Int. J. Cancer 98 (2002) 547-553
20. Scanlan M.J., Gordon C.M., Williamson B., Lee S.Y., Chen Y.T., Stockert E., Jungbluth A., Ritter G., Jager D., Jager E., Knuth A., and Old L.J. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int. J. Cancer 98 (2002) 485-492
21. Chen Y.T., Scanlan M.J., Venditti C.A., Chua R., Theiler G., Stevenson B.J., Iseli C., Gure A.O., Vasicek T., Strausberg R.L., Jongeneel C.V., Old L.J., and Simpson A.J. Identification of cancer/testis-antigen genes by massively parallel signature sequencing. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 7940-7945
22. Hofmann O., Caballero O.L., Stevenson B.J., Chen Y.T., Cohen T., Chua R., Maher C.A., Panji S., Schaefer U., Kruger A., Lehvaslaiho M., Carninci P., Hayashizaki Y., Jongeneel C.V., Simpson A.J., Old L.J., and Hide W. Genome-wide analysis of cancer/testis gene expression. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 20422-20427
23. Liggins A.P., Guinn B.A., Hatton C.S., Pulford K., and Banham A.H. Serologic detection of diffuse large B-cell lymphoma-associated antigens. Int. J. Cancer 110 (2004) 563-569
24. Adams M.D., Dubnick M., Kerlavage A.R., Moreno R., Kelley J.M., Utterback T.R., Nagle J.W., Fields C., and Venter J.C. Sequence identification of 2,375 human brain genes. Nature 355 (1992) 632-634
25. Adams M.D., Kerlavage A.R., Fields C., and Venter J.C. 3,400 new expressed sequence tags identify diversity of transcripts in human brain. Nat. Genet. 4 (1993) 256-267
26. Brown S., Chang J.L., Sadee W., and Babbitt P.C. A semiautomated approach to gene discovery through expressed sequence tag data mining: discovery of new human transporter genes. AAPS PharmSci 5 (2003) E1
27. De Young M.P., Damania H., Scheurle D., Zylberberg C., and Narayanan R. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer. In Vivo 16 (2002) 239-248
28. Parmigiani R.B., Bettoni F., Vibranovski M.D., Lopes M.H., Martins W.K., Cunha W., Soares F.A., Simpson A.J., de Souza S.J., and Camargo A.A. Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 18066-18071
29. Baysal B.E., van Schothorst E.M., Farr J.E., James M.R., Devilee P., and Richard 3rd C.W. A high-resolution STS, EST, and gene-based physical map of the hereditary paraganglioma region on chromosome 11q23. Genomics 44 (1997) 214-221
30. Hudson T.J., Colbert A.M., Reeve M.P., Bae J.S., Lee M.K., Nussbaum R.L., Budarf M.L., Emanuel B.S., and Foote S. Isolation and regional mapping of 110 chromosome 22 STSs. Genomics 24 (1994) 588-592
31. Lee Y., Sultana R., Pertea G., Cho J., Karamycheva S., Tsai J., Parvizi B., Cheung F., Antonescu V., White J., Holt I., Liang F., and Quackenbush J. Cross-referencing eukaryotic genomes: TIGR Orthologous Gene Alignments (TOGA). Genome Res. 12 (2002) 493-502
32. Mignone F., Anselmo A., Donvito G., Maggi G.P., Grillo G., and Pesole G. Genome-wide identification of coding and non-coding conserved sequence tags in human and mouse genomes. BMC Genomics 9 (2008) 277
33. Tugendreich S., Bassett Jr. D.E., McKusick V.A., Boguski M.S., and Hieter P. Genes conserved in yeast and humans. Hum. Mol. Genet. 3 (1994) 1509-1517
34. Xu Q., and Lee C. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res. 31 (2003) 5635-5643
35. Xu Q., Modrek B., and Lee C. Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res. 30 (2002) 3754-3766
36. Bonizzoni P., Mauri G., Pesole G., Picardi E., Pirola Y., and Rizzi R. Detecting alternative gene structures from spliced ESTs: a computational approach. J. Comput. Biol. 16 (2009) 43-66
37. Hui L., Zhang X., Wu X., Lin Z., Wang Q., Li Y., and Hu G. Identification of alternatively spliced mRNA variants related to cancers by genome-wide ESTs alignment. Oncogene 23 (2004) 3013-3023
38. Kan Z., Rouchka E.C., Gish W.R., and States D.J. Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res. 11 (2001) 889-900
39. Xie H., Zhu W.Y., Wasserman A., Grebinskiy V., Olson A., and Mintz L. Computational analysis of alternative splicing using EST tissue information. Genomics 80 (2002) 326-330
40. Beaudoing E., and Gautheret D. Identification of alternate polyadenylation sites and analysis of their tissue distribution using EST data. Genome Res. 11 (2001) 1520-1526
41. Iseli C., Stevenson B.J., de Souza S.J., Samaia H.B., Camargo A.A., Buetow K.H., Strausberg R.L., Simpson A.J., Bucher P., and Jongeneel C.V. Long-range heterogeneity at the 3′ ends of human mRNAs. Genome Res. 12 (2002) 1068-1074
42. Kamasawa M., and Horiuchi J. Identification and characterization of polyadenylation signal (PAS) variants in human genomic sequences based on modified EST clustering. In Silico Biol. 8 (2008) 347-361
43. Aradhya S., Bardaro T., Galgoczy P., Yamagata T., Esposito T., Patlan H., Ciccodicola A., Munnich A., Kenwrick S., Platzer M., D'Urso M., and Nelson D.L. Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum. Mol. Genet. 10 (2001) 2557-2567
44. Yan W., Rajkovic A., Viveiros M.M., Burns K.H., Eppig J.J., and Matzuk M.M. Identification of Gasz, an evolutionarily conserved gene expressed exclusively in germ cells and encoding a protein with four ankyrin repeats, a sterile-alpha motif, and a basic leucine zipper. Mol. Endocrinol. 16 (2002) 1168-1184
45. Kelso J., Visagie J., Theiler G., Christoffels A., Bardien S., Smedley D., Otgaar D., Greyling G., Jongeneel C.V., McCarthy M.I., Hide T., and Hide W. eVOC: a controlled vocabulary for unifying gene expression data. Genome Res. 13 (2003) 1222-1230
46. Guinn B.A., Bland E.A., Lodi U., Liggins A.P., Tobal K., Petters S., Wells J.W., Banham A.H., and Mufti G.J. Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia. Biochem. Biophys. Res. Commun. 335 (2005) 1293-1304
47. Osorio E.C., de Souza J.E., Zaiats A.C., de Oliveira P.S., and de Souza S.J. pp-Blast: a "pseudo-parallel" Blast. Braz. J. Med. Biol. Res. 36 (2003) 463-464
48. Galante P.A., Sakabe N.J., Kirschbaum-Slager N., and de Souza S.J. Detection and evaluation of intron retention events in the human transcriptome. Rna 10 (2004) 757-765
49. Chirgwin J.M., Przybyla A.E., MacDonald R.J., and Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18 (1979) 5294-5299